Aclaris Therapeutics, Inc.

ACRSNASDAQHealthcare● Active

$4.36

+$0.00(+0.00%)

Market Cap$525794200

P/E Ratio—

52W High$5.15

52W Low$1.343

Avg Volume1.8M

Open$4.42

Beta0.80

Employees Ownership Insider Trades

Aclaris Therapeutics, Inc. (ACRS) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · ACRS · as of Feb 26, 2026

Latest filing snapshot

+9+14.06%vs prior year

Aclaris Therapeutics, Inc. (ACRS) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

Change (1Y)

Growth % (1Y)

+14.06%

Revenue / Employee

$107.2K

Net Income / Employee

$-889.4K

Market Cap

$526M

ACRS Employee Count

2015 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-02-26	2025-12-31	73	+9	+14.06%
2025-02-27	2024-12-31	64	-27	-29.67%
2024-02-27	2023-12-31	91	-14	-13.33%
2023-02-23	2022-12-31	105	+28	+36.36%
2022-02-24	2021-12-31	77	+17	+28.33%
2021-02-25	2020-12-31	60	-17	-22.08%
2020-02-25	2019-12-31	77	-92	-54.44%
2019-03-18	2018-12-31	169	+73	+76.04%
2018-03-12	2017-12-31	96	+65	+209.68%
2017-03-15	2016-12-31	31	+13	+72.22%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

Editas Medicine, Inc.

Allogene Therapeutics, Inc.

Aclaris Therapeutics, Inc.YOU

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · ACRS peer comparison

About ACRS employees

ACRS Employees · Headcount

Aclaris Therapeutics, Inc. (ACRS) employee data is sourced from the annual SEC 10-K filing. As of 2025, Aclaris Therapeutics, Inc. had 73 full-time employees globally. Full-time employees only. Global consolidated headcount.

Aclaris Therapeutics, Inc. employs 73 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $107,205, reflecting the company's operational efficiency.

Aclaris Therapeutics, Inc.'s workforce increased by 9 (14.06%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Aclaris Therapeutics, Inc.'s revenue per employee of $107,205 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

ACRS Employees · 5 questions

As of the latest SEC 10-K filing (2025), Aclaris Therapeutics, Inc. had 73 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Aclaris Therapeutics, Inc. employee counthow many employees does Aclaris Therapeutics, Inc. haveACRS total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-26